| Hims & Hers Health, Inc: Hers launches free Metabolic Deep Dive to help show UK women what's really holding back their weight loss | Hers launches free Metabolic Deep Dive to help show UK women what's really holding back their weight loss
New YouGov research finds 61% of UK women are trying to lose weight, yet many are working... ► Artikel lesen |
| Hims-&-Hers-Aktie -26%: 49% Wachstum - und trotzdem ein Crash! | Die Hims-&-Hers-Aktie erlebt einen heftigen Ausverkauf. Nach enttäuschenden Quartalszahlen verlor das Papier am Dienstag weitere -16,6% auf 19,13 US$ und damit innerhalb von zwei Handelstagen rund -26%.... ► Artikel lesen |
| Gewinnwarnung: Hims & Hers schockt mit Quartalszahlen - Aktie stürzt ab | © Foto: Dall-EHims & Hers enttäuscht mit seinen Quartalszahlen und senkt die Gewinnprognose für 2026. Die Aktie stürzt zweistellig ab Enthaltene Werte: US4330001060Den vollständigen Artikel lesen ► Artikel lesen |
| XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -3- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameKYG200801002 CBAK... ► Artikel lesen |
| Akari Therapeutics Plc: Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers | Patent filing covers PH1 payload's unique ability to disrupt multiple cancer-driving pathways in addition to its overall cytotoxic mechanism Expands intellectual property portfolio supporting Akari's... ► Artikel lesen |
| Akari Therapeutics Plc: Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy | AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari's novel PH1 RNA spliceosome-modulating... ► Artikel lesen |
| Laser Photonics Corp.: LASE to Premiere Quantum Bullet at Counter UAS Technology Conference in Washington, D.C. | Executive Chairman Dmitri Nikitin to Address Senior Military, Government and Industry Leaders as Featured Speaker ORLANDO, FL / ACCESS Newswire / November 19, 2026 / LASE Corp. (NASDAQ:LASE), an emerging... ► Artikel lesen |
| Laser Photonics Corp.: LASE Corp Reports Third Quarter 2026 Results | Third Quarter Net Sales Increase 25% and Net Loss Improves 46% Compared with Third Quarter 2025 ORLANDO, FL / ACCESS Newswire / November 12, 2026 / LASE Corp. (NASDAQ:LASE), an emerging laser technology... ► Artikel lesen |
| Laser Photonics Corp.: LASE Strengthens Board of Directors with Appointments of Tim Peterman and Sanjay Adhav | ORLANDO, FL / ACCESS Newswire / November 9, 2026 / LASE Corp. (NASDAQ:LASE), an emerging laser technology company developing quantum mechanics applications for the defense, pharmaceutical, semiconductor... ► Artikel lesen |